Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity-Reference-Cited by-同舟云学术

Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity

Published:2017-12-13 Issue:420 Volume:9 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Paris Luisa¹^ORCID,Magni Ruben¹^ORCID,Zaidi Fatima¹^ORCID,Araujo Robyn²^ORCID,Saini Neal¹,Harpole Michael¹,Coronel Jorge³^ORCID,Kirwan Daniela E.⁴^ORCID,Steinberg Hannah⁵^ORCID,Gilman Robert H.⁵,Petricoin Emanuel F.¹,Nisini Roberto⁶,Luchini Alessandra¹^ORCID,Liotta Lance¹

Affiliation:

1. George Mason University, Manassas, VA 20110, USA.

2. Queensland University of Technology, Brisbane, Queensland 4000, Australia.

3. Universidad Peruana Cayetano Heredia, Lima 31, Peru.

4. St. George’s Hospital, London SW17 0QT, UK.

5. Johns Hopkins University, Baltimore, MD 21205, USA.

6. Istituto Superiore di Sanità, Rome 00161, Italy.

Abstract

The Mycobacterium tuberculosis –specific antigen lipoarabinomannan measured in the urine of HIV-negative, pulmonary TB-infected patients correlates with disease severity.

Funder

NIH Office of the Director

Bill and Melinda Gates Foundation

Ministero della Salute

Horizon 2020

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference36 articles.

1. World Health Organization (WHO) Global Tuberculosis Report 2015 (WHO Technical Report Series WF 300 WHO 2015).

2. Defining the Needs for Next Generation Assays for Tuberculosis